Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short Antibiotic Course to Decrease Post ERCP Cholangitis
NCT03087656Phase 4Unknown
- Sponsor
- University of Southern California
- Start
- Mar 2017
- Primary completion
- Feb 2024
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of ceftriaxone, levofloxacin in cholangitis, sponsored by University of Southern California. Status: unknown.
02
Drugs
ceftriaxonelevofloxacin
03
Conditions
cholangitis
Beyond the preview
Go deeper on NCT03087656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03087656.